Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2003 (LINC02003) is a human gene that encodes a long intergenic non-coding RNA, a type of RNA molecule longer than 200 nucleotides that does not overlap with protein-coding genes[1][3][7]. LINC02003 is classified as a lincRNA, which are known to regulate gene expression at multiple levels, such as chromatin remodeling, genome architecture, RNA stabilization, and transcriptional regulation, sometimes acting as enhancers or in fine-tuning the expression of neighboring genes[3][7]. The biological function of LINC02003 itself has not been well characterized, and there is currently no established evidence linking it to therapeutic targeting or disease-specific roles. LINC02003 does not encode a protein and is generally considered to function through RNA-mediated regulatory mechanisms. There are no known drugs, biomarkers, or safety concerns directly associated with LINC02003 in the current literature[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2003 (LINC02003).